Top Markets
Coin of the day
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc.

OTLC
Classement en actions #30395
Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage... Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma. Beyond oncology, OT-101 is also being explored for its potential in treating various viral diseases, including severe acute respiratory syndrome (SARS) and coronaviruses. The company's pipeline further includes OXi4503, which is being advanced for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and CA4P, intended for the treatment of advanced metastatic melanoma.
Prix de l'action
$0.03834
Dernière synchronisation: 2026-08-18
Capitalisation boursière
$17.01M
Changement (1 jour)
-4.15%
Changement (1 an)
-24.82%
Pays
US
Échange Oncotelic Therapeutics, Inc. (OTLC)

Catégorie

Historique des divisions d’actions pour Oncotelic Therapeutics, Inc. (OTLC)
L’action Oncotelic Therapeutics, Inc. (symbole : OTLC) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 19, 2026.
Une action OTLC achetée avant le Aug 19, 2026 équivaudrait aujourd’hui à 0 actions OTLC.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE